123
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Development and Validation Features of the Patient Benefit Index for the Treatment of Allergic Rhinoconjunctivitis with Allergen Immunotherapy

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 611-621 | Published online: 11 May 2022

References

  • Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–764. doi:10.1183/09031936.04.00013904
  • Eriksson J, Ekerljung L, Rönmark E, et al. Update of prevalence of self-reported allergic rhinitis and chronic nasal symptoms among adults in Sweden. Clin Respir J. 2012;6(3):159–168. doi:10.1111/j.1752-699X.2011.00269.x
  • Passali D, Cingi C, Staffa P, Passali F, Muluk NB, Bellussi ML. The International study of the allergic rhinitis survey: outcomes from 4 geographical regions. Asia Pac Allergy. 2018;8(1):e7. doi:10.5415/apallergy.2018.8.e7
  • Marco R, De, Cappa V, Accordini S, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J. 2012;39(4):883–892. doi:10.1183/09031936.00061611
  • Zhang Y, Zhang L. Increasing prevalence of allergic rhinitis in China. Allergy Asthma Immunol Res. 2018;11(2):156–169. doi:10.4168/aair.2019.11.2.156
  • Ha J, Lee SW, Yon DK. Ten-year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008–2017. Clin Exp Pediatr. 2020;63(7):278–283. doi:10.3345/cep.2019.01291
  • Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8–160. doi:10.1111/j.1398-9995.2007.01620.x
  • Strachan DP, Rutter CE, Asher MI, et al. Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: global asthma network phase I. Pediatr Allergy Immunol. 2022;33(1):e13656. doi:10.1111/pai.13656
  • Langen U, Schmitz R, Steppuhn H. Häufigkeit allergischer Erkrankungen in Deutschland: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):698–706. doi:10.1007/s00103-012-1652-7
  • Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schäfer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol. 2011;165(4):865–873. doi:10.1111/j.1365-2133.2011.10436.x
  • Augustin M, Franzke N, Beikert FC, et al. Allergies in Germany – prevalence and perception by the public. J Dtsch Dermatol Ges. 2013;11(6):514–520. doi:10.1111/j.1610-0387.2012.08049.x
  • Knudgaard MH, Andreasen TH, Ravnborg N, et al. Rhinitis prevalence and association with atopic dermatitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2021;127(1):49–56.e1. doi:10.1016/j.anai.2021.02.026
  • Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin. 2006;22(6):1203–1210. doi:10.1185/030079906X112552
  • Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372(9643):1049–1057.
  • Pawankar R, Bunnag C, Khaltaev N, Bousquet J. Allergic rhinitis and its impact on asthma in Asia pacific and the ARIA update 2008. World Allergy Organ J. 2012;5(Suppl3):S212–7.
  • Franzke N, Schäfer I, Jost K, et al. A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis. Allergy. 2011;66(5):665–670. doi:10.1111/j.1398-9995.2010.02515.x
  • Marple BF, Fornadley JA, Patel AA, et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg. 2007;136(6 Suppl):S107–24. doi:10.1016/j.otohns.2007.02.031
  • Schmitt J, Schwarz K, Stadler E, Wüstenberg EG. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study. J Allergy Clin Immunol. 2015;136(6):1511–1516. doi:10.1016/j.jaci.2015.07.038
  • Rychlik R, Rusche H, Augustin M. Systematik der Nutzenbewertung von Arzneimitteln. Gesundh Ökon Qual Manag. 2004;9(04):245–252. doi:10.1055/s-2004-813336
  • Bundesministerium für Gesundheit. Das Gesetz zur Neuordnung des Arzneimittelmarktes (AMNOG) 2016. Available from: http://www.bmg.bund.de/glossarbegriffe/a/das-gesetz-zur-neuordnung-des-arzneimittelmarktes-amnog.html. Accessed August 26, 2016.
  • Teeling-Smith G. Measuring Health: A Practical Approach/Edited by George Teeling Smith. Chichester: Wiley; 1988.
  • Lienert GA, Raatz U. Testaufbau und Testanalyse. 6. Auflage. Weinheim: Beltz; 1998.
  • Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40(2):171–178.
  • Brock D. Quality of life measures in health care and medical ethics. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. New York: Lippincott-Raven; 1996:497–510.
  • Bowling A. Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales/Ann Bowling. Buckingham: Open University Press; 1995.
  • Augustin M, Reich C, Schaefer I, Zschocke I, Rustenbach SJ. Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne. J Dtsch Dermatol Ges. 2008;6(2):113–120. doi:10.1111/j.1610-0387.2007.06540.x
  • Bortz J. Statistik für Human- und Sozialwissenschaftler: Mit … 242 Tabellen. 6., vollst. überarb. und aktualisierte Aufl. Heidelberg: Springer; 2005.
  • Steiger JH. Tests for comparing elements of a correlation matrix. Psychol Bull. 1980;87(2):245–251. doi:10.1037/0033-2909.87.2.245
  • Zwingmann C. Zielorientierte Ergebnismessung (ZOE) mit dem IRES-Patientenfragebogen: eine kritische Zwischenbilanz. Rehabilitation. 2003;42(4):226–235. doi:10.1055/s-2003-41646
  • Steffanowski A, Lichtenberg S, Schmidt J, Huber C, Wittmann WW, Nübling R. Ergebnisqualität psychosomatischer Rehabilitation: zielerreichungsskalierung auf der Basis einer strukturierten Therapiezielliste. Rehabilitation. 2004;43(4):219–232. doi:10.1055/s-2004-828295
  • Kiresuk TJ, Sherman RE. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4(6):443–453. doi:10.1007/BF01530764
  • Ottenbacher KJ, Cusick A. Goal attainment scaling as a method of clinical service evaluation. Am J Occup Ther. 1990;44(6):519–525. doi:10.5014/ajot.44.6.519
  • Clark MS, Caudrey DJ. Evaluation of rehabilitation services: the use of goal attainment scaling. Int Rehabil Med. 1983;5(1):41–45. doi:10.3109/09638288309166938